"We're at a point where we need to hold two truths: That GLP-1s are legitimate evidence-based treatments for obesity, but that they also sit inside our culture, which has intense weight pressure, weight stigma and eating disorder risk," she says
The tirzepatide glycine blend addresses different concerns than the levocarnitine version, focusing more on tolerability and compound stability than on metabolic enhancement
As genotypes with multiple mutations appear at later timepoints than single mutants, the analysis of intermediate activity suggests that redesign expanded functional sequences to include those closer to the starting point, allowing the redesigned protease to adapt to the 413 substrate in less time and with fewer mutations than the WT protease
San Diego-based Dexcom designed the Dexcom One system as an easy-to-use, real-time CGM (rt-CGM) that it aims to make more affordable and accessible for people with diabetes in the UK
Just live with someone who is carnivore and ask to inspect their toilet bowl
